Vargeese Chandra 4
4 · Wave Life Sciences Ltd. · Filed Jul 24, 2024
Insider Transaction Report
Form 4
Vargeese Chandra
See Remarks
Transactions
- Exercise/Conversion
Share Option (right to buy)
2024-07-22−68,210→ 75,332 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (68,210 underlying) - Exercise/Conversion
Ordinary Shares
2024-07-22$2.48/sh+68,210$169,161→ 185,061 total
Footnotes (2)
- [F1]Includes 2,559 ordinary shares acquired on July 14, 2023, 4,135 ordinary shares acquired on January 14, 2024, and 3,533 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.
- [F2]The share options that were exercised via cash purchase in this reportable transaction were fully vested.